| Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ... Jama 321 (1), 69-79, 2019 | 1137 | 2019 |
| Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes HC Gerstein, N Sattar, J Rosenstock, C Ramasundarahettige, R Pratley, ... New England journal of medicine 385 (10), 896-907, 2021 | 480 | 2021 |
| Triglyceride lowering with pemafibrate to reduce cardiovascular risk A Das Pradhan, RJ Glynn, JC Fruchart, JG MacFadyen, ES Zaharris, ... New England Journal of Medicine 387 (21), 1923-1934, 2022 | 392 | 2022 |
| Probiotics in prevention and treatment of obesity: a critical view N Kobyliak, C Conte, G Cammarota, AP Haley, I Styriak, L Gaspar, ... Nutrition & metabolism 13, 1-13, 2016 | 387 | 2016 |
| A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial N Kobyliak, L Abenavoli, G Mykhalchyshyn, L Kononenko, L Boccuto, ... | 221 | 2018 |
| Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, D Kyriienko, ... Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (5), 617-624, 2018 | 191 | 2018 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 190 | 2022 |
| Pathophysiological role of host microbiota in the development of obesity N Kobyliak, O Virchenko, T Falalyeyeva Nutrition journal 15, 1-12, 2015 | 179 | 2015 |
| Linagliptin effects on heart failure and related outcomes in individuals with type 2 diabetes mellitus at high cardiovascular and renal risk in CARMELINA DK McGuire, JH Alexander, OE Johansen, V Perkovic, J Rosenstock, ... Circulation 139 (3), 351-361, 2019 | 168 | 2019 |
| Caffeine and cardiovascular diseases: critical review of current research A Zulli, RM Smith, P Kubatka, J Novak, Y Uehara, H Loftus, T Qaradakhi, ... European Journal of Nutrition, 1-13, 2016 | 119 | 2016 |
| Probiotics function and modulation of the immune system in allergic diseases M Eslami, A Bahar, M Keikha, M Karbalaei, NM Kobyliak, B Yousefi Allergologia et Immunopathologia 48 (6), 771-788, 2020 | 109 | 2020 |
| Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study N Kobyliak, L Abenavoli, T Falalyeyeva, G Mykhalchyshyn, L Boccuto, ... | 94 | 2018 |
| Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 L Abenavoli, M Masarone, V Peta, N Milic, N Kobyliak, S Rouabhia, ... World journal of gastroenterology: WJG 20 (41), 15233, 2014 | 90 | 2014 |
| Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a … J Rosenstock, V Perkovic, JH Alexander, ME Cooper, N Marx, MJ Pencina, ... Cardiovascular diabetology 17, 1-15, 2018 | 89 | 2018 |
| Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease L Abenavoli, T Falalyeyeva, L Boccuto, O Tsyryuk, N Kobyliak Pharmaceuticals 11 (4), 104, 2018 | 86 | 2018 |
| Crosstalk between gut microbiota and antidiabetic drug action Y Kyriachenko, T Falalyeyeva, O Korotkyi, N Molochek, N Kobyliak World journal of diabetes 10 (3), 154, 2019 | 79 | 2019 |
| Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult … O Savcheniuk, N Kobyliak, M Kondro, O Virchenko, T Falalyeyeva, ... BMC complementary and alternative medicine 14, 1-17, 2014 | 75 | 2014 |
| Antioxidative effects of cerium dioxide nanoparticles ameliorate age-related male infertility: optimistic results in rats and the review of clinical clues for integrative … NM Kobyliak, TM Falalyeyeva, OG Kuryk, TV Beregova, PM Bodnar, ... EPMA Journal 6, 1-22, 2015 | 74 | 2015 |
| Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial GJ Biessels, C Verhagen, J Janssen, E van den Berg, B Zinman, ... Diabetes care 42 (10), 1930-1938, 2019 | 73 | 2019 |
| Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats N Kobyliak, O Virchenko, T Falalyeyeva, M Kondro, T Beregova, P Bodnar, ... Biomedicine & Pharmacotherapy 90, 608-614, 2017 | 71 | 2017 |
Tetyana Falalyeyeva, Тетяна Фалалє...Professor, Taras Shevchenko National University of Kyiv在 knu.ua 的电子邮件经过验证
